These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 681814)

  • 41. A rapid method for determination of acetylation phenotype using dapsone.
    Philip PA; Roberts MS; Rogers HJ
    Br J Clin Pharmacol; 1984 Apr; 17(4):465-9. PubMed ID: 6721993
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Determination of acetylator phenotype in Sri Lankans.
    Perera PL; Weerasinghe WM
    Ceylon Med J; 1987 Mar; 32(1):29-34. PubMed ID: 3690726
    [No Abstract]   [Full Text] [Related]  

  • 43. Acetylator status and diabetic neuropathy.
    Shenfield GM; McCann VJ; Tjokresetio R
    Diabetologia; 1982 Jun; 22(6):441-4. PubMed ID: 7106444
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification and kinetic characterization of acetylator genotype-dependent and -independent arylamine carcinogen N-acetyltransferases in hamster bladder cytosol.
    Yerokun T; Kirlin WG; Trinidad A; Ferguson RJ; Ogolla F; Andrews AF; Brady PK; Hein DW
    Drug Metab Dispos; 1989; 17(3):231-7. PubMed ID: 2568902
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Construction of Syrian hamster lines congenic at the polymorphic acetyltransferase locus (NAT2): acetylator genotype-dependent N- and O-acetylation of arylamine carcinogens.
    Hein DW; Doll MA; Rustan TD; Gray K; Ferguson RJ; Feng Y
    Toxicol Appl Pharmacol; 1994 Jan; 124(1):16-24. PubMed ID: 8291057
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relationship between acetylator phenotype and intensity of the hypoglycaemic effect of a suplhonamide preparation in children with insulin-dependent diabetes.
    Hadasová E; Brysová V; Utĕsený J; Macků M
    Bratisl Lek Listy; 1991 Dec; 92(12):609-14. PubMed ID: 1806177
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Direct and indirect determination of an acetylator phenotype in patients during treatment with hydralazine].
    McNair A; Kristensen MB; Angelo HR; Christensen JM
    Ugeskr Laeger; 1981 Jun; 143(27):1696-9. PubMed ID: 7292741
    [No Abstract]   [Full Text] [Related]  

  • 48. Relationship between N-acetylator phenotype and susceptibility toward hydrazine-induced lethal central nervous system toxicity in the rabbit.
    Hein DW; Weber WW
    J Pharmacol Exp Ther; 1984 Mar; 228(3):588-92. PubMed ID: 6707910
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A semi-automated Bratton & Marshall micromethod for determining acetylator phenotype of rabbits using the Abbott Bichromatic Analyzer-100.
    Whitehouse LW; Paul CJ
    J Clin Chem Clin Biochem; 1979 Aug; 17(8):533-6. PubMed ID: 501298
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Comparative analysis of N-acetylation polymorphism in humans as determined by phenotyping and genotyping].
    Goldenkova-Pavlova IV; Bruskin SA; Abdeev RM; Markarova EV; Bigvava SG; Radkevich LA; Kozhekbaeva ZhM; Glotov AS; Gra OA; Zasedatelev AS; Nasedkina TV; Kurdanov KhA; Piruzian ES
    Genetika; 2006 Aug; 42(8):1143-50. PubMed ID: 17025166
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Extrahepatic expression of N-acetylator genotype in the inbred hamster.
    Hein DW; Kirlin WG; Ogolla F; Trinidad A
    Drug Metab Dispos; 1987; 15(1):68-73. PubMed ID: 2881761
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acetylator phenotypes: effect of age.
    Gachályi B; Vas A; Hajós P; Káldor A
    Eur J Clin Pharmacol; 1984; 26(1):43-5. PubMed ID: 6714291
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acetylation pharmacogenetics. The slow acetylator phenotype is caused by decreased or absent arylamine N-acetyltransferase in human liver.
    Grant DM; Mörike K; Eichelbaum M; Meyer UA
    J Clin Invest; 1990 Mar; 85(3):968-72. PubMed ID: 2312737
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Importance of acetylator phenotype in the identity of Asian populations.
    Zaid RB; Nargis M; Neelotpol S; Sayeed MA; Banu A; Shurovi S; Hassan KN; Salimullah M; Ali L; Azad Khan AK
    Hum Biol; 2007 Jun; 79(3):363-8. PubMed ID: 18078208
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Acetylator phenotype determination in the rabbit: sulphamethazine or sulphadiazine, the choice of a substrate.
    du Souich P; Courteau H
    J Pharm Pharmacol; 1981 Apr; 33(4):261-3. PubMed ID: 6115918
    [No Abstract]   [Full Text] [Related]  

  • 56. Slow acetylation in mice is caused by a labile and catalytically impaired mutant N-acetyltransferase (NAT2 9).
    De Leon JH; Martell KJ; Vatsis KP; Weber WW
    Drug Metab Dispos; 1995 Dec; 23(12):1354-61. PubMed ID: 8689943
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inheritance of acetylator phenotype in mice.
    Tannen RH; Weber WW
    J Pharmacol Exp Ther; 1980 Jun; 213(3):480-4. PubMed ID: 6970808
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Human acetylator polymorphism: estimate of allele frequency in Libya and details of global distribution.
    Karim AK; Elfellah MS; Evans DA
    J Med Genet; 1981 Oct; 18(5):325-30. PubMed ID: 7328611
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Acetylator genotype-dependent expression of arylamine N-acetyltransferase and N-hydroxyarylamine O-acetyltransferase in Syrian inbred hamster intestine and colon. Identity with the hepatic acetylation polymorphism.
    Ogolla F; Ferguson RJ; Kirlin WG; Trinidad A; Andrews AF; Mpezo M; Hein DW
    Drug Metab Dispos; 1990; 18(5):680-5. PubMed ID: 1981720
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Debrisoquine hydroxylation phenotype, acetylation phenotype, and ABO blood groups as genetic host factors of lung cancer risk.
    Roots I; Drakoulis N; Ploch M; Heinemeyer G; Loddenkemper R; Minks T; Nitz M; Otte F; Koch M
    Klin Wochenschr; 1988; 66 Suppl 11():87-97. PubMed ID: 2846954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.